ELV has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ELV has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's EBIT by its Interest Expense. Elevance Health's EBIT for the three months ended in Sep. 2024 was $1,673 Mil. Elevance Health's Interest Expense for the three months ended in Sep. 2024 was $-300 Mil. Elevance Health's interest coverage for the quarter that ended in Sep. 2024 was 5.58. The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Elevance Health's Interest Coverage or its related term are showing as below:
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
The historical data trend for Elevance Health's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Elevance Health Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Interest Coverage | Get a 7-Day Free Trial | 9.02 | 8.96 | 11.02 | 9.93 | 8.49 |
Elevance Health Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Interest Coverage | Get a 7-Day Free Trial | 7.39 | 4.86 | 12.09 | 11.66 | 5.58 |
For the Healthcare Plans subindustry, Elevance Health's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Plans industry and Healthcare sector, Elevance Health's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Elevance Health's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
If Interest Expense is negative and EBIT is positive, then
Interest Coverage | = | -1 | * | EBIT | / | Interest Expense |
Else if Interest Expense is negative and EBIT is negative, then
The company did not have earnings to cover the interest expense. |
Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then
The company had no debt (1). |
Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Elevance Health's Interest Coverage for the fiscal year that ended in Dec. 2023 is calculated as
Here, for the fiscal year that ended in Dec. 2023, Elevance Health's Interest Expense was $-1,030 Mil. Its EBIT was $8,745 Mil. And its Long-Term Debt & Capital Lease Obligation was $23,246 Mil.
Interest Coverage | = | -1 | * | EBIT (A: Dec. 2023 ) | / | Interest Expense (A: Dec. 2023 ) |
= | -1 | * | 8745 | / | -1030 | |
= | 8.49 |
Elevance Health's Interest Coverage for the quarter that ended in Sep. 2024 is calculated as
Here, for the three months ended in Sep. 2024, Elevance Health's Interest Expense was $-300 Mil. Its EBIT was $1,673 Mil. And its Long-Term Debt & Capital Lease Obligation was $24,688 Mil.
Interest Coverage | = | -1 | * | EBIT (Q: Sep. 2024 ) | / | Interest Expense (Q: Sep. 2024 ) |
= | -1 | * | 1673 | / | -300 | |
= | 5.58 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's Financial Strength is.
Elevance Health (NYSE:ELV) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Thank you for viewing the detailed overview of Elevance Health's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.
Ramiro G Peru | director | WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46260 |
Gail Boudreaux | director, officer: President and CEO | GENZYME CORP., 500 KENDALL STREET, CAMBRIDGE MA 02142 |
Dixon Robert L Jr | director | 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204 |
Felicia F Norwood | officer: Exec VP & President, GBD | 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204 |
Kendrick Charles Morgan Jr | officer: EVP & President, Commercial | 220 VIRGINIA AVE, INDIANAPOLIS IN 46204 |
Ronald W Penczek | officer: SVP, Chief Accounting Officer | 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204 |
Blair Williams Todt | officer: EVP and Chief Legal Officer | 8735 HENDERSON ROAD, TAMPA FL 33625 |
Mark Kaye | officer: EVP & CFO Designate | 7 WORLD TRADE CENTER, 250 GREENWICH ST, NEW YORK NY 10007 |
Gloria M Mccarthy | officer: EVP, Office of the CEO | WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204 |
Deanna D Strable-soethout | director | C/O PRINCIPAL FINANCIAL GROUP, 711 HIGH ST., DES MOINES IA 50392 |
Peter D Haytaian | officer: EVP & Pres., Govt. Bus. Div. | 220 VIRGINIA AVE, INDIANAPOLIS IN 46204 |
Susan D. Devore | director | C/O PREMIER, INC., 13034 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277 |
Ryan M. Schneider | director | 1680 CAPITAL ONE DRIVE, MCLEAN VA 22102 |
John E Gallina | officer: SVP & Chief Accounting Officer | 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204 |
Julie A Hill | director | WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204 |
From GuruFocus
By Business Wire • 04-03-2024
By GuruFocus Research • 07-18-2024
By GuruFocus Research • 08-07-2024
By Business Wire • 05-20-2024
By GuruFocus Research • 03-06-2024
By GuruFocus Research • 04-19-2024
By GuruFocus Research • 04-26-2024
By GuruFocus Research • 06-10-2024
By GuruFocus Research • 04-18-2024
By Business Wire • 06-26-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.